Regulatory submission - Glossary

A regulatory submission is an official evidence dossier submitted to a health authority, such as the FDA or EMA, to obtain permission to market a drug. It is not a single lab test but a comprehensive collection of validated analytical data, manufacturing details, and quality control procedures. For peptides, this filing must demonstrate identity, purity, and strength through Chemistry, Manufacturing, and Controls (CMC) data, impurity analysis, and stability testing.

Regulatory submissions determine the credibility of peptide lab reports

The credibility of a peptide lab report depends on whether the product was part of a regulatory submission reviewed by a health authority. Only an official review by agencies like the FDA or EMA confirms that the data has been assessed and the benefits outweigh the risks. Research-grade peptides are not approved for human use, regardless of how detailed a vendor's lab report appears.

Lab documents like CoAs or DMFs are not regulatory submissions

A Certificate of Analysis (CoA) reports results for a single batch and may be part of a submission, but a standalone CoA from an unregulated supplier does not equal a reviewed filing.
A Drug Master File (DMF) provides technical data to support other drug applications but is not a marketing application itself.
Analytical method validation data confirms that testing methods are accurate, but it serves as a component of a submission rather than a replacement for a full marketing application.

Regulatory submissions determine the credibility of peptide lab reports

Lab documents like CoAs or DMFs are not regulatory submissions

Sources